- Article
- Source: Campus Sanofi
- 22 Oct 2023
SPARTA study
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/Diabetes/sparta-study/Hero/Post-GLP-Therapy.jpg/jcr:content/Post%20GLP%20Therapy.jpg)
![toujeo logo](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/Diabetes/Image/toujeo-content-page-logo2--2-.jpg/jcr:content/toujeo-content-page-logo2%20(2).jpg)
Sanofi is here to support you and your patients.
Ask us your questions about our products, patient materials or organising a meeting.
![SPARTA summary](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/sparta-summary.jpg/jcr:content/sparta-summary.jpg)
Sparta Video
In the short video (2.35 min) you’ll learn about the results of the SPARTA study in T1 diabetes. This descriptive, retrospective study represents the real-world experience of using Toujeo® in 300 patients with T1DM in the UK.
MAT-XU-2205632 (v5.0) Date of Preparation: October 2023